Treatment may be offered to hundreds with severe form of disease, most often found in people of Mediterranean, Asian and Middle Eastern heritage
People living with a rare genetic blood disorder in England will be offered a “life-changing” new treatment on the NHS, in what has been described as a historic moment.
Casgevy, which is a one-off gene therapy, has been approved for use on the NHS in England for people living with a severe form of thalassaemia.
Previous Post